ACER Acer Therapeutics

Acer Therapeutics Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Acer Therapeutics Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

03-28 22:59

HC Wainwright & Co. Reiterates Buy on Acer Therapeutics, Maintains $12 Price Target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Acer Therapeutics (NASDAQ:ACER) with a Buy and maintains $12 price target.

03-28 22:50

H.C. Wainwright Sticks to Their Buy Rating for Acer Therapeutics (ACER)

03-28 22:47

Acer: Cash and Cash Equivalents Available at Dec 31, Gross Proceed of $7.0M From Loan, $4.1M From ATM Facility Loans to Dec 31, $2.7M From Sale of Securities Are Equivalents to Fund Operating and Cap Requirements Into Middle 2Q >ACER

Acer: Cash and Cash Equivalents Available at Dec 31, Gross Proceed of $7.0M From Loan, $4.1M From ATM Facility Loans to Dec 31, $2.7M From Sale of Securities Are Equivalents to Fund Operating and

03-28 04:08

Acer Therapeutics Q4 EPS $(0.54) Misses $(0.37) Estimate

Acer Therapeutics (NASDAQ:ACER) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.37) by 45.95 percent. This is a 74.19 percent decrease over losses of

03-28 04:05

Acer Therapeutics: Ended 4Q With $2.3M in Cash and Cash Equivalents >ACER

Acer Therapeutics: Ended 4Q With $2.3M in Cash and Cash Equivalents >ACER

03-28 04:04

Press Release: Acer Therapeutics Reports Q4 and Full Year 2022 Financial Results and Provides Corporate Update

Acer Therapeutics Reports Q4 and Full Year 2022 Financial Results and Provides Corporate Update NEWTON, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutic

03-28 04:03

Acer Therapeutics 4Q Loss/Shr 54c >ACER

Acer Therapeutics 4Q Loss/Shr 54c >ACER

03-28 04:03

Acer Therapeutics Stock Dips on $2.7M Securities Offering

03-22 20:16

Acer Therapeutics Announces $2.675 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

NEWTON, Mass., March 22, 2023 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serio

03-22 20:04